Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.225 USD | +1.42% | +2.06% | -16.02% |
Apr. 04 | Acumen Pharmaceuticals Signs Deal With Lonza to Manufacture Alzheimer's Treatment Drug | MT |
Apr. 04 | Lonza Enters Manufacturing Agreement for Acumen’s Alzheimer’s Disease Drug Candidate | MT |
Official Publications
No official publication found
- Stock Market
- Equities
- ABOS Stock
- News Acumen Pharmaceuticals, Inc.
- Official Publications